The SNB + ALND group also exhibited a greater proportion of hormone receptor-positive breast cancer, which typically shows less responsiveness to chemotherapy compared to HER2-positive or triple-negative breast cancer types. The gene discussed is NR4A1; the disease is triple-negative breast carcinoma.